PMC:7455510 / 9957-10217
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T73 | 38-41 | Disease | denotes | HLH | http://purl.obolibrary.org/obo/MONDO_0015540 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T71 | 68-69 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T72 | 225-226 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T51 | 3-16 | Chemical | denotes | Dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879 |
| T52 | 246-260 | Chemical | denotes | hydrocortisone | http://purl.obolibrary.org/obo/CHEBI_17650 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T105 | 0-87 | Sentence | denotes | ***Dexamethasone was given as per the HLH 2004 trial, although with a shorter duration: |
| T106 | 88-260 | Sentence | denotes | 10 mg/m2/day for 7 days, followed by 5 mg/m2/day for another 7 days, followed by 2.5 mg/m2 for 7 days and 1.25 mg/m2 for 2 days and then a tapering dose with hydrocortisone |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T119 | 3-16 | CHEBI:41879;CHEBI:41879 | denotes | Dexamethasone |
| T120 | 246-260 | CHEBI:24751;CHEBI:24751 | denotes | hydrocortisone |
| T85530 | 3-16 | CHEBI:41879;CHEBI:41879 | denotes | Dexamethasone |
| T80219 | 246-260 | CHEBI:24751;CHEBI:24751 | denotes | hydrocortisone |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 223 | 3-16 | Chemical | denotes | Dexamethasone | MESH:D003907 |